Trevisani F, Bernardi M, Gasbarrini A, Tamè M R, Giancane S, Andreone P, Baraldini M, Cursaro C, Ligabue A, Gasbarrini G
Istituto di Patologia Speciale Medica e Metodologia Clinica, University of Bologna, Italy.
J Hepatol. 1992 Sep;16(1-2):190-6. doi: 10.1016/s0168-8278(05)80114-x.
Renal function, plasma renin activity, plasma aldosterone concentration and urine excretion of free norepinephrine were evaluated in 13 cirrhotics without previous or ongoing ascites and in 13 healthy subjects, after 6 days of controlled electrolyte intake (40 mmol of Na and 70 mmol of K per day) and during 24 h of recumbency. Plasma concentrations of the atrial natriuretic peptide (ANP) were also measured in 8 patients and 8 controls. Despite a low-normal filtered load of sodium (14.6 +/- 1.2 vs. 17.1 +/- 1.2 mmol/min), cirrhotic patients showed supernormal natriuresis (141.5 +/- 14.1 vs. 78.8 +/- 8.6 mmol/day; p < 0.001). Whereas the fractional excretion of sodium in these patients was twice that of controls (0.70 +/- 0.05 vs. 0.36 +/- 0.04%; p < 0.001), potassium excretion (42.5 +/- 2.7 vs. 43.1 +/- 2.7 mmol/day) and urine volume (1270 +/- 98 vs. 1452 +/- 148 ml/day) did not differ. In cirrhotics, plasma renin activity was reduced (0.50 +/- 0.12 vs. 1.39 +/- 0.33 ng/ml/h; p < 0.02), and plasma aldosterone concentration tended to be lower (66 +/- 10 vs. 86 +/- 9 pg/ml; p = 0.09), while urine norepinephrine excretion did not significantly differ from controls (961 +/- 120 vs. 782 +/- 43 ng/h). ANP was higher in patients than in controls (92 +/- 17 vs. 48 +/- 9 pg/ml; p < 0.05). Natriuresis was directly correlated with ANP (r = 0.69, p < 0.005) and ANP/plasma aldosterone ratio (r = 0.63; p < 0.01) in patients and healthy subjects taken together.(ABSTRACT TRUNCATED AT 250 WORDS)
在13例既往无腹水且目前也无腹水的肝硬化患者及13名健康受试者中,在进行6天的电解质摄入量控制(每天40 mmol钠和70 mmol钾)后以及在24小时卧位期间,评估了肾功能、血浆肾素活性、血浆醛固酮浓度和尿游离去甲肾上腺素排泄量。还对8例患者和8名对照者测量了血浆心钠素(ANP)浓度。尽管肝硬化患者的钠滤过负荷略低于正常水平(14.6±1.2对17.1±1.2 mmol/分钟),但其钠利尿作用超常(141.5±14.1对78.8±8.6 mmol/天;p<0.001)。这些患者的钠分数排泄率是对照者的两倍(0.70±0.05对0.36±0.04%;p<0.001),而钾排泄量(42.5±2.7对43.1±2.7 mmol/天)和尿量(1270±98对1452±148 ml/天)无差异。肝硬化患者的血浆肾素活性降低(0.50±0.12对1.39±0.33 ng/ml/小时;p<0.02),血浆醛固酮浓度趋于降低(66±10对86±9 pg/ml;p = 0.09),而尿去甲肾上腺素排泄量与对照者无显著差异(961±120对782±43 ng/小时)。患者的ANP高于对照者(92±17对48±9 pg/ml;p<0.05)。综合患者和健康受试者来看,钠利尿作用与ANP(r = 0.69,p<0.005)以及ANP/血浆醛固酮比值(r = 0.63;p<0.01)直接相关。(摘要截短至250字)